Heidi O'neill - Nov 3, 2021 Form 4 Insider Report for NIKE, Inc. (NKE)

Role
PRES: CONSUMER AND MKTPLC
Signature
/s/ Kelsey A. Baldwin, attorney-in-fact for Ms. O'Neill
Stock symbol
NKE
Transactions as of
Nov 3, 2021
Transactions value $
-$1,611,880
Form type
4
Date filed
11/5/2021, 04:31 PM
Previous filing
Aug 3, 2021
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKE Class B Common Stock Sale -$780K -4.59K -4.01% $170.00 110K Nov 3, 2021 Direct F1, F2
transaction NKE Class B Common Stock Options Exercise $443K +7.5K +6.83% $59.10 117K Nov 3, 2021 Direct F3
transaction NKE Class B Common Stock Sale -$1.28M -7.5K -6.39% $170.00 110K Nov 3, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKE Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7.5K -100% $0.00* 0 Nov 3, 2021 Class B Common Stock 7.5K $59.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
F2 Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.
F3 Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
F4 Stock Option granted on 07/20/2017 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.